---
abstract: ''
authors:
- Ebell, Mark H
category: Case Study
clinical_significance: High
cme_credits: 0.0
doi: ''
evidence_level: ''
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/37327180/
file_path: 2023/06/twice-daily-low-dose-aspirin-is-similar-to-enoxaparin-for-th.md
issue: '6'
keywords:
- Anticoagulants
- Inpatients
- Humans
- Venous Thromboembolism
- Enoxaparin
- Aspirin
- Fractures, Bone
last_updated: '2025-08-09'
mesh_terms:
- Humans
- Enoxaparin
- Anticoagulants
- Inpatients
- Venous Thromboembolism
- Aspirin
- Fractures, Bone
original_format: PubMed
pages: Online
patient_population: Adults
peer_reviewed: true
pmid: '37327180'
processed_date: '2025-08-09'
publication_date: '2023-06-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-09'
reading_time_minutes: 1
source: American family physician
specialties:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Twice-Daily Low-Dose Aspirin Is Similar to Enoxaparin for Thromboprophylaxis
  After Inpatient Treatment for Fracture.
topics:
- Family Medicine
volume: '107'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '37327180'
  title: Twice-Daily Low-Dose Aspirin Is Similar to Enoxaparin for Thromboprophylaxis
    After Inpatient Treatment for Fracture.
  authors:
  - last_name: Ebell
    fore_name: Mark H
    initials: MH
    affiliation: University of Georgia, Athens, Ga.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '107'
    issue: '6'
  publication_info:
    year: '2023'
    month: '06'
    full_date: '2023-06-01'
  article_ids: {}
  mesh_terms:
  - descriptor: Humans
    major_topic: false
  - descriptor: Enoxaparin
    major_topic: false
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
  - descriptor: Anticoagulants
    major_topic: false
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
  - descriptor: Inpatients
    major_topic: false
  - descriptor: Venous Thromboembolism
    major_topic: true
    qualifiers:
    - qualifier: drug therapy
      major_topic: false
    - qualifier: prevention & control
      major_topic: false
  - descriptor: Aspirin
    major_topic: false
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
  - descriptor: Fractures, Bone
    major_topic: true
  publication_types: *id001
---

# Twice-Daily Low-Dose Aspirin Is Similar to Enoxaparin for Thromboprophylaxis After Inpatient Treatment for Fracture.

**Authors:** Ebell, Mark H

**Published in:** American family physician | Vol. 107, No. 6 | 2023-06-01

**Links:** [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/37327180/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Humans, Enoxaparin, Anticoagulants, Inpatients, Venous Thromboembolism, Aspirin, Fractures, Bone

## Article Content

# Twice-Daily Low-Dose Aspirin Is Similar to Enoxaparin for Thromboprophylaxis After Inpatient Treatment for Fracture.

**Authors:** Ebell, Mark H

**Published in:** American family physician | Vol. 107, No. 6 | 2023-06-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/37327180/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Humans, Enoxaparin, Anticoagulants, Inpatients, Venous Thromboembolism, Aspirin, Fractures, Bone

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/37327180/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/37327180/) (reference)

---

*Processed: 2025-08-09* | *PubMed Enhanced: 2025-07-30*
